Stay updated on Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial
Sign up to get notified when there's something new on the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page.

Latest updates to the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may or may not relate to the study, and the revision version is updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the notice about a lapse in government funding and potential processing delays; the page's study details remain unchanged.SummaryDifference0.5%

- Check35 days agoChange DetectedMinor UI/layout adjustments and a timestamp update were made; core study details appear unchanged.SummaryDifference0.6%

- Check63 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference5%

- Check70 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, updating the core version information. The 'Back to Top' item was removed as a minor UI change.SummaryDifference0.3%

Stay in the know with updates to Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page.